Background Sleep-disordered breathing (SDB) is a common comorbidity in patients with
heart failure (HF) and is associated with worse prognosis. Objectives This study evaluated …

Rationale Adaptive servo ventilation (ASV) is contraindicated in patients with systolic heart
failure (HF) who have a left ventricular ejection fraction (LVEF) below 45% and predominant …

Purpose FACE is a prospective cohort study designed to assess the effect of adding
adaptive servoventilation (ASV) to standard care on morbidity and mortality in patients with …

Background Adaptive servoventilation (ASV) is a new therapeutic modality to treat sleep‐
disordered breathing (SDB) especially for central sleep apnoea associated with Cheyne …

Introduction Both types of sleep‐disordered breathing (SDB), obstructive and central sleep
apnoea (OSA and CSA, respectively), are common in patients with heart failure and reduced …

Background Adaptive servoventilation (ASV) has demonstrated efficacy in treating sleep-
disordered breathing (SDB) in patients with heart failure (HF), but large randomized trials …

Sleep‐disordered breathing—comprising obstructive sleep apnoea (OSA), central sleep
apnoea (CSA), or a combination of the two—is found in over half of heart failure (HF) …

Background Despite the efficacy of adaptive servo-ventilation (ASV) in suppressing central
sleep apnea (CSA), its impact on long-term outcomes is debatable. We aim to identify …

Purpose Adaptive servoventilation (ASV) has been reported to show improvement in
patients with sleep-disordered breathing (SDB) and heart failure (HF); however, its role as a …

Background: This study tested the hypothesis that adaptive servo-ventilation (ASV) therapy
improves the prognosis of heart failure (HF) patients, regardless of the severity of sleep …